AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2014
May 20, 2014
32106_dirs_2014-05-20_eeea0d8e-710b-4586-8a58-d941c9d74605.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2014-05-20
Reporting Person: COHEN RAYMOND W (Director, Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-20 | Common Stock | P | 4000 | $2.39 | Acquired | 7216 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.39 to $2.40, inclusive. The reporting person undertakes to provide BioLife Solutions, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2: The total shares held reflects a 14:1 reverse stock split effected by BioLife Solutions, Inc. on January 29, 2014.